Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-directed RNA polymerase II subunit RPB2 (POLR2B) is the **second largest subunit of RNA polymerase II**, a multiprotein enzyme complex that catalyzes the transcription of DNA into precursors of messenger RNA (mRNA), small nuclear RNA (snRNA), and microRNA in eukaryotic cells[1][2][3][5]. POLR2B associates with other core subunits to form the active site of the polymerase, participating in the catalysis of RNA synthesis by appending nucleotides and supporting transcription fidelity, including 3'-5' exonuclease proofreading activity[2][5]. Proper POLR2B function is required for all gene expression, making it fundamental to cell viability, and alterations or dysregulation of its activity are implicated in various diseases with transcriptional disturbances, such as cancer and viral infections[2][5]. Because it is vital for general gene transcription, POLR2B is not considered a typical small-molecule drug target, and attempts to therapeutically inhibit its function would have profound toxicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-directed RNA polymerase II subunit RPB2 (POLR2B).